Trial intelligence / Profile preview

Recombinant Streptokinase vs Urokinase in Pulmonary Embolism (RESUPEC)

NCT00968929Phase 4Completed

Sponsor
Beijing Chaoyang Hospital
Start
Jun 2006
Primary completion
May 2009
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 4 trial of recombinant streptokinase in pulmonary embolism (PE), sponsored by Beijing Chaoyang Hospital. Started Jun 2006; status: completed.

02

Drugs

recombinant streptokinase
03

Conditions

pulmonary embolism (PE)

Beyond the preview

Go deeper on NCT00968929.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00968929.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call